Blog

Immunotherapy Combination Tolerable & Effective in Advanced Kidney Cancer Patients – Technology Networks


http://www.newsgram.com/

Immunotherapy Combination Tolerable & Effective in Advanced Kidney Cancer Patients
Technology Networks
Combining an anti-angiogenesis agent, which blocks blood vessel formation, with an immunotherapy agent, was found to have promising anti-tumor activity and no unexpected side effects in an early-phase clinical trial in patients with advanced kidney
New combination therapy found effective in kidney cancer patientsHindustan Times


New Combo Therapy Found Effective In Kidney Cancer Patientshttp://www.newsgram.com/

all 3 news articles »

2018-02-12 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.